Shares of Merck fell 9% Tuesday after the company reported that in the second quarter, it saw a decrease in shipments of its HPV vaccine Gardasil in China, a significant market for the drug.
The company brought in $2.48 billion in sales of Gardasil in the second quarter, slightly lower than…
[ad_2]
Source link
